Hoffman, M <br/><br/>
Severe intrahepatic cholestasis in patients treated with recombinant interleukin-2 and lymphokine-activated killer cells.  [electronic resource] 

 -  Journal of cancer research and clinical oncology  1989 
 - 175-8 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0171-5216 
<br/><br/><label>Standard No.: </label>10.1007/BF00397920  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Blood Transfusion, Autologous<br/>Cholestasis, Intrahepatic--etiology<br/>Combined Modality Therapy<br/>Female<br/>Humans<br/>Hyperbilirubinemia--etiology<br/>Immunization, Passive--adverse effects<br/>Interleukin-2--adverse effects<br/>Killer Cells, Natural--drug effects<br/>Leukapheresis<br/>Liver Diseases--complications<br/>Liver Function Tests<br/>Lymphocyte Activation--drug effects<br/>Melanoma--secondary<br/>Middle Aged<br/>Recombinant Proteins--adverse effects